Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Comparison of clinical characteristics in patients with Vogt-Koyanagi-Harada disease with and without anti-retinal antibodies.

Hashimoto Y, Saito W, Namba K, Mizuuchi K, Iwata D, Noda K, Kanda A, Ishida S.

Graefes Arch Clin Exp Ophthalmol. 2019 Aug;257(8):1751-1758. doi: 10.1007/s00417-019-04330-1. Epub 2019 May 7.

PMID:
31065846
2.

Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases.

Regula JT, Lundh von Leithner P, Foxton R, Barathi VA, Chui Ming GC, Tun SBB, Wey YS, Iwata D, Dostalek M, Moelleken J, Stubenrauch KG, Nogoceke E, Widmer G, Strassburger P, Koss MJ, Klein C, Shima DT, Hartmann G.

EMBO Mol Med. 2019 May;11(5). pii: e10666. doi: 10.15252/emmm.201910666. No abstract available.

3.

Cyclosporine and prednisolone combination therapy as a potential therapeutic strategy for relentless placoid chorioretinitis.

Uraki T, Namba K, Mizuuchi K, Iwata D, Ohno S, Kitaichi N, Ishida S.

Am J Ophthalmol Case Rep. 2019 Mar 23;14:87-91. doi: 10.1016/j.ajoc.2019.03.005. eCollection 2019 Jun.

4.

Immunohistochemical and Immunocytochemical Analyses in Patients with Vitreoretinal Lymphoma.

Kase S, Namba K, Kanno-Okada H, Onozawa M, Hidaka D, Iwata D, Mizuuchi K, Fukuhara T, Fukuhara J, Kitaichi N, Matsuno Y, Ishida S.

Ocul Immunol Inflamm. 2018 Oct 18:1-9. doi: 10.1080/09273948.2018.1533984. [Epub ahead of print]

PMID:
30335535
5.

Non-parametric detection of atmospheric radon concentration anomalies related to earthquakes.

Iwata D, Nagahama H, Muto J, Yasuoka Y.

Sci Rep. 2018 Aug 29;8(1):13028. doi: 10.1038/s41598-018-31341-5.

6.

Two cases of cytomegalovirus panuveitis in immunocompetent patients.

Sakai M, Takase H, Namba K, Mizuuchi K, Iwata D, Ishida S.

Am J Ophthalmol Case Rep. 2018 Jan 17;10:189-191. doi: 10.1016/j.ajoc.2018.01.025. eCollection 2018 Jun.

7.

A Proinflammatory Function of Toll-Like Receptor 2 in the Retinal Pigment Epithelium as a Novel Target for Reducing Choroidal Neovascularization in Age-Related Macular Degeneration.

Feng L, Ju M, Lee KYV, Mackey A, Evangelista M, Iwata D, Adamson P, Lashkari K, Foxton R, Shima D, Ng YS.

Am J Pathol. 2017 Oct;187(10):2208-2221. doi: 10.1016/j.ajpath.2017.06.015. Epub 2017 Jul 21.

8.

Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases.

Regula JT, Lundh von Leithner P, Foxton R, Barathi VA, Gemmy Cheung CM, Bo Tun SB, Wey YS, Iwata D, Dostalek M, Moelleken J, Stubenrauch KG, Nogoceke E, Widmer G, Strassburger P, Koss MJ, Klein C, Shima DT, Hartmann G.

EMBO Mol Med. 2017 Jul;9(7):985. doi: 10.15252/emmm.201707895. No abstract available.

9.

Early post-treatment choroidal thickness to alert sunset glow fundus in patients with Vogt-Koyanagi-Harada disease treated with systemic corticosteroids.

Hirooka K, Saito W, Namba K, Mizuuchi K, Iwata D, Hashimoto Y, Ishida S.

PLoS One. 2017 Feb 27;12(2):e0172612. doi: 10.1371/journal.pone.0172612. eCollection 2017.

10.

Invariant natural killer T cells play dual roles in the development of experimental autoimmune uveoretinitis.

Satoh M, Namba KI, Kitaichi N, Endo N, Kitamei H, Iwata D, Ohno S, Ishida S, Onoé K, Watarai H, Taniguchi M, Ishibashi T, Stein-Streilein J, Sonoda KH, Van Kaer L, Iwabuchi K.

Exp Eye Res. 2016 Dec;153:79-89. doi: 10.1016/j.exer.2016.10.003. Epub 2016 Oct 5.

PMID:
27720708
11.

Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases.

Regula JT, Lundh von Leithner P, Foxton R, Barathi VA, Cheung CM, Bo Tun SB, Wey YS, Iwata D, Dostalek M, Moelleken J, Stubenrauch KG, Nogoceke E, Widmer G, Strassburger P, Koss MJ, Klein C, Shima DT, Hartmann G.

EMBO Mol Med. 2016 Nov 2;8(11):1265-1288. doi: 10.15252/emmm.201505889. Print 2016 Nov. Erratum in: EMBO Mol Med. 2019 May;11(5):.

12.

Choroidal circulation impairment during the anterior recurrence of Vogt-Koyanagi-Harada disease confirmed with indocyanine green angiography and laser speckle flowgraphy.

Takemoto Y, Namba K, Mizuuchi K, Iwata D, Uno T, Ohno S, Hirooka K, Hashimoto Y, Saito W, Sugiyama K, Ishida S.

Acta Ophthalmol. 2016 Nov;94(7):e629-e636. doi: 10.1111/aos.13024. Epub 2016 Apr 15.

13.

Evaluating the efficacy of epinastine ophthalmic solution using a conjunctivitis allergen challenge model in patients with birch pollen allergic conjunctivitis.

Tagawa Y, Namba K, Nakazono Y, Iwata D, Ishida S.

Allergol Int. 2017 Apr;66(2):338-343. doi: 10.1016/j.alit.2016.08.011. Epub 2016 Oct 6.

14.

Serial Frequencies and Clinical Features of Uveitis in Hokkaido, Japan.

Iwata D, Mizuuchi K, Aoki K, Horie Y, Kase S, Namba K, Ohno S, Ishida S, Kitaichi N.

Ocul Immunol Inflamm. 2017;25(sup1):S15-S18. doi: 10.1080/09273948.2016.1184286. Epub 2016 Jul 20.

PMID:
27438588
15.

Diagnostic efficacy of cell block method for vitreoretinal lymphoma.

Kase S, Namba K, Iwata D, Mizuuchi K, Kitaichi N, Tagawa Y, Okada-Kanno H, Matsuno Y, Ishida S.

Diagn Pathol. 2016 Mar 17;11:29. doi: 10.1186/s13000-016-0479-1.

16.

HLA-B51 Carriers are Susceptible to Ocular Symptoms of Behçet Disease and the Association between the Two Becomes Stronger towards the East along the Silk Road: A Literature Survey.

Horie Y, Meguro A, Ohta T, Lee EB, Namba K, Mizuuchi K, Iwata D, Mizuki N, Ota M, Inoko H, Ishida S, Ohno S, Kitaichi N.

Ocul Immunol Inflamm. 2017 Feb;25(1):37-40. doi: 10.3109/09273948.2015.1136422. Epub 2016 Mar 8. Review.

PMID:
26954704
17.

Significant role of the choroidal outer layer during recovery from choroidal thickening in Vogt-Koyanagi-Harada disease patients treated with systemic corticosteroids.

Hirooka K, Saito W, Namba K, Mizuuchi K, Iwata D, Hashimoto Y, Ishida S.

BMC Ophthalmol. 2015 Dec 18;15:181. doi: 10.1186/s12886-015-0171-3.

18.

Choroidal thickening prior to anterior recurrence in patients with Vogt-Koyanagi-Harada disease.

Tagawa Y, Namba K, Mizuuchi K, Takemoto Y, Iwata D, Uno T, Fukuhara T, Hirooka K, Kitaichi N, Ohno S, Ishida S.

Br J Ophthalmol. 2016 Apr;100(4):473-7. doi: 10.1136/bjophthalmol-2014-306439. Epub 2015 Aug 10.

19.

Experimental autoimmune uveitis and other animal models of uveitis: An update.

Bansal S, Barathi VA, Iwata D, Agrawal R.

Indian J Ophthalmol. 2015 Mar;63(3):211-8. doi: 10.4103/0301-4738.156914. Review.

20.

Amelioration of experimental autoimmune uveoretinitis by inhibition of glyceraldehyde-derived advanced glycation end-product formation.

Dong Z, Iwata D, Kitaichi N, Takeuchi M, Sato M, Endo N, Iwabuchi K, Ando R, Fukuhara J, Kinoshita S, Lennikov A, Kitamura M, Mizuuchi K, Kanda A, Noda K, Namba K, Yamagishi S, Ohno S, Ishida S.

J Leukoc Biol. 2014 Dec;96(6):1077-85. doi: 10.1189/jlb.3A0513-288RRR. Epub 2014 Sep 8.

PMID:
25201803
21.

Cytokines and Biologics in non-infectious autoimmune uveitis: bench to bedside.

Agrawal R, Iyer J, Connolly J, Iwata D, Teoh S.

Indian J Ophthalmol. 2014 Jan;62(1):74-81. doi: 10.4103/0301-4738.126187. Review.

22.

Bacterial endophthalmitis caused by an intraocular cilium in a patient under treatment with infliximab.

Jin XH, Namba K, Saito W, Iwata D, Ishida S.

J Ophthalmic Inflamm Infect. 2013 Jun 5;3(1):50. doi: 10.1186/1869-5760-3-50.

23.

Clinical features of human T lymphotropic virus type 1-associated uveitis in Hokkaido, Japan.

Kase S, Namba K, Kitaichi N, Iwata D, Ohno S, Ishida S.

Jpn J Ophthalmol. 2013 Jul;57(4):379-84. doi: 10.1007/s10384-013-0244-x. Epub 2013 Apr 23.

PMID:
23608951
24.

Fabrication of ferromagnetic nanoconstriction using atomic force microscopy nanoscratching.

Jang K, Ishibashi Y, Iwata D, Suganuma H, Yamada T, Takemura Y.

J Nanosci Nanotechnol. 2011 Dec;11(12):10945-8.

PMID:
22409031
25.

Correlation between elevation of serum antinuclear antibody titer and decreased therapeutic efficacy in the treatment of Behçet's disease with infliximab.

Iwata D, Namba K, Mizuuchi K, Kitaichi N, Kase S, Takemoto Y, Ohno S, Ishida S.

Graefes Arch Clin Exp Ophthalmol. 2012 Jul;250(7):1081-7. doi: 10.1007/s00417-011-1908-1. Epub 2012 Jan 11.

26.

Functional expression of carnitine/organic cation transporter OCTN1/SLC22A4 in mouse small intestine and liver.

Sugiura T, Kato S, Shimizu T, Wakayama T, Nakamichi N, Kubo Y, Iwata D, Suzuki K, Soga T, Asano M, Iseki S, Tamai I, Tsuji A, Kato Y.

Drug Metab Dispos. 2010 Oct;38(10):1665-72. doi: 10.1124/dmd.110.032763. Epub 2010 Jul 2.

PMID:
20601551
27.

Gene knockout and metabolome analysis of carnitine/organic cation transporter OCTN1.

Kato Y, Kubo Y, Iwata D, Kato S, Sudo T, Sugiura T, Kagaya T, Wakayama T, Hirayama A, Sugimoto M, Sugihara K, Kaneko S, Soga T, Asano M, Tomita M, Matsui T, Wada M, Tsuji A.

Pharm Res. 2010 May;27(5):832-40. doi: 10.1007/s11095-010-0076-z. Epub 2010 Mar 12.

PMID:
20224991
28.

Amelioration of experimental autoimmune uveoretinitis with nuclear factor-{kappa}B Inhibitor dehydroxy methyl epoxyquinomicin in mice.

Iwata D, Kitaichi N, Miyazaki A, Iwabuchi K, Yoshida K, Namba K, Ozaki M, Ohno S, Umezawa K, Yamashita K, Todo S, Ishida S, Onoé K.

Invest Ophthalmol Vis Sci. 2010 Apr;51(4):2077-84. doi: 10.1167/iovs.09-4030. Epub 2009 Nov 11.

PMID:
19907030
29.

Prevention of experimental autoimmune uveoretinitis by blockade of osteopontin with small interfering RNA.

Iwata D, Kitamura M, Kitaichi N, Saito Y, Kon S, Namba K, Morimoto J, Ebihara A, Kitamei H, Yoshida K, Ishida S, Ohno S, Uede T, Onoé K, Iwabuchi K.

Exp Eye Res. 2010 Jan;90(1):41-8. doi: 10.1016/j.exer.2009.09.008. Epub 2009 Sep 18.

30.

Low prevalence of juvenile-onset Behcet's disease with uveitis in East/South Asian people.

Kitaichi N, Miyazaki A, Stanford MR, Iwata D, Chams H, Ohno S.

Br J Ophthalmol. 2009 Nov;93(11):1428-30. doi: 10.1136/bjo.2008.154476. Epub 2009 Aug 9.

31.

Molecular subtyping of feline immunodeficiency virus from cats in Melbourne.

Iwata D, Holloway SA.

Aust Vet J. 2008 Oct;86(10):385-9. doi: 10.1111/j.1751-0813.2008.00336.x.

PMID:
18826508
32.

Involvement of carnitine/organic cation transporter OCTN2 (SLC22A5) in distribution of its substrate carnitine to the heart.

Iwata D, Kato Y, Wakayama T, Sai Y, Kubo Y, Iseki S, Tsuji A.

Drug Metab Pharmacokinet. 2008;23(3):207-15.

33.

Total hip arthroplasty outcomes assessment using functional and radiographic scores to compare canine systems.

Iwata D, Broun HC, Black AP, Preston CA, Anderson GI.

Vet Comp Orthop Traumatol. 2008;21(3):221-30.

PMID:
18536848
34.

Effect of high fat diet on NKT cell function and NKT cell-mediated regulation of Th1 responses.

Miyazaki Y, Iwabuchi K, Iwata D, Miyazaki A, Kon Y, Niino M, Kikuchi S, Yanagawa Y, Kaer LV, Sasaki H, Onoé K.

Scand J Immunol. 2008 Mar;67(3):230-7. doi: 10.1111/j.1365-3083.2007.02062.x. Epub 2008 Jan 22.

35.

Anti-inflammatory effect of angiotensin type 1 receptor antagonist on endotoxin-induced uveitis in rats.

Miyazaki A, Kitaichi N, Ohgami K, Iwata D, Jin XH, Iwabuchi K, Morohashi T, Ohno S, Onoé K.

Graefes Arch Clin Exp Ophthalmol. 2008 May;246(5):747-57. Epub 2007 Dec 18.

PMID:
18087711
36.

Ocular features of Behcet's disease: an international collaborative study.

Kitaichi N, Miyazaki A, Iwata D, Ohno S, Stanford MR, Chams H.

Br J Ophthalmol. 2007 Dec;91(12):1579-82.

37.

Functional analysis of organic cation transporter OCTNs in mouse renal brush border membrane.

Kubo Y, Nakamura T, Iwata D, Kato Y, Tsuji A.

Pharmazie. 2006 Feb;61(2):171. No abstract available.

PMID:
16526568
38.

Cribrarione B, a new naphthoquinone pigment from the myxomycete Cribraria cancellata.

Iwata D, Ishibashi M, Yamamoto Y.

J Nat Prod. 2003 Dec;66(12):1611-2.

PMID:
14695806
39.

Anti-ganglioside GD1a monoclonal antibody recognizes senile plaques in the brains of patients with Alzheimer-type dementia.

Nishinaka T, Iwata D, Shimada S, Kosaka K, Suzuki Y.

Neurosci Res. 1993 Jul;17(2):171-6.

PMID:
7694209
40.

Changes of host cell infiltration into Meth A fibrosarcoma tumor during the course of regression induced by injections of a BCG nucleic acid fraction.

Kuramoto E, Watanabe N, Iwata D, Yano O, Shimada S, Tokunaga T.

Int J Immunopharmacol. 1992 Jul;14(5):773-82.

PMID:
1380950
41.

Preparation of monoclonal antibodies against a glycolipid asialo GM1.

Shimada S, Iwata D.

Microbiol Immunol. 1987;31(9):923-33.

42.

Existence of two kinds of thiol protease inhibitors in rat serum.

Iwata D, Hirado M, Niinobe M, Fujii S.

Biochem Biophys Res Commun. 1982 Feb 26;104(4):1525-31. No abstract available.

PMID:
7041913
43.

Purification and properties of thiol protease inhibitor from rat liver cytosol.

Hirado M, Iwata D, Niinobe M, Fujii S.

Biochim Biophys Acta. 1981 Jun 29;669(1):21-7.

PMID:
7028126

Supplemental Content

Support Center